top of page
Executive Spotlights

Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics

Cambridge, MA, October 2, 2023 (PRNewswire) -- Flagship Pioneering, the bioplatform innovation firm, and ProFound™ Therapeutics, an enterprise focused on expanding our understanding of the human proteome to unlock a realm of potential novel medicines, announced that Dr. John Lepore will assume the roles of CEO-Partner at Flagship Pioneering and Chief Executive Officer at ProFound, effective October 16, 2023.

Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page